Gene therapy edges towards commercial reality
By Reuters,
Reuters
| 05. 25. 2009
LONDON, (Reuters) - Gene therapy may be about to become a commercial reality, 20 years after the first experiments with the ground-breaking medical technology.
But the tale of two biotech companies - one British and one U.S. - suggests a tricky road ahead.
On the one side, French authorities recently allowed an experimental gene medicine from Britain's Ark Therapeutics to be prescribed to certain patients with brain cancer, even though it is not approved for general use.
The news boosted hopes that the European Medicines Agency will clear Ark's drug Cerepro for sale across the European Union in the second half of 2009.
By contrast, U.S.-based Introgen Therapeutics - which had been competing to get the first gene therapy approved in Western markets - filed for bankruptcy in December, after a regulatory setback for its experimental cancer drug Advexin.
The last two decades have seen more than 1,470 clinical trials involving gene therapy, two-thirds of them aimed at cancer, according to the Journal of Gene Medicine.
But the only drug to get to market so far has been one for...
Related Articles
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
If you’ve been online or caught the news in the past few weeks, you’ve probably come across Sydney Sweeney, her “great genes jeans,” and much debate over whether they reflect a resurgence of eugenics in American politics and culture.
In case you missed it, here’s what happened. At the end of July, US-based clothing company American Eagle released a new ad campaign. In one ad, Sweeney breathily recites the following, while lying back to zip up her jeans:
Genes are...
By Ryan Cross, Endpoints News | 08.19.2025
Human eggs are incredibly rare cells. The ovary typically produces only 400 mature eggs across a woman’s life. But biologists in George Church’s lab at Harvard University — a group that’s never content with nature’s limits — just got a...
By Staff, National Women's Law Center | 08.13.2025
INTRODUCTION
Baby bonuses. Motherhood medals. Fertility tracking. You may have heard of these policy proposals as solutions from the Trump administration to help encourage women to have more children.
Besides falling short of ensuring that people have what they need...
